In Australia, researchers have begun clinical trials of a new type of COVID-19 vaccine, the nasal spray. The vaccine is believed to be more effective than AstraZeneca and Pfizer.
Vaccinations are accelerating in Australia. It is planned to introduce a nasal spray that will “attack the virus” when it enters the body.
Nucleus Network head Dr. Paul Griffin said that while other drugs mainly protect against the development of serious symptoms of COVID-19, this one aims to reduce the risk of infection.
- Brief Anger Hampers Blood Vessel Function Leading to Increased Risk of Heart Disease and Stroke – New Study
- New Blood Test Pinpoints Future Stroke Risk – Study Identifies Inflammatory Molecules as Key Biomarker
- Enceladus: A Potential Haven for Extraterrestrial Life in its Hidden Ocean Depths
- New Experiment: Dark Matter Is Not As ‘DARK’ As All We Think
- Scientists in Fear of This New Predator From Red Sea Eating Native Species in Mediterranean
“The main benefit is, when we give the vaccine via the same route that the pathogen or the virus gets in through, then hopefully the response will be more adept at actually stopping the virus getting in,” he said.
So, we will get a response that is particularly active at that site, which will hopefully mean that people are much less likely to get infected, which is something that we really want to see with vaccines for this virus
The nasal spray will be available in 1 or 2 years, the researchers said.
The government plans to vaccinate every Australian seeking the vaccine by the end of 2021. Australia has already reported about 30,000 cases of COVID. At the same time, more than 9 hundred people died.
Photo by Brook Mitchell/Getty Images
